SCHEMBL24818170

SCHEMBL24818170

CC[N+](CC)=c1ccc2c(-c3ccccc3C(=O)O)c3ccc([N+](C)(CC)CC)cc3oc-2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 5/20 0.42
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ BLM P54132 3/20 0.42
▸ POLB P06746 3/20 0.42
▸ PPARG P37231 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ NCOR2 Q9Y618 1/20 0.42
▸ FTO Q9C0B1 2/20 0.41
▸ FPR2 P25090 4/20 0.41
▸ TGM2 P21980 1/20 0.41
▸ ABCB1 P08183 1/20 0.40
▸ ATM Q13315 2/20 0.39
▸ CFTR P13569 1/20 0.39
▸ PAX8 Q06710 1/20 0.39
▸ GOPC Q9HD26 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ THRB P10828 2/20 0.38
▸ RECQL P46063 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23134951 0.87 USP2 (0.42) USP2MEN1KMT2ABLMPOLB
SCHEMBL19494774 0.85 USP2 (0.53) USP2MEN1KMT2ABLMPOLB
SCHEMBL12763951 0.85 POLB (0.50) USP2MEN1KMT2ABLMPOLB
SCHEMBL17109310 0.85 ABCB1 (0.44) USP2MEN1KMT2ABLMPOLB
SCHEMBL19494880 0.83 ABCB1 (0.45) USP2MEN1KMT2ABLMPOLB
SCHEMBL3903552 0.82 MEN1 (0.61) USP2MEN1KMT2ABLMPOLB
SCHEMBL29593395 0.82 MEN1 (0.61) USP2MEN1KMT2ABLMPOLB
SCHEMBL19495008 0.82 ABCB1 (0.42) USP2MEN1KMT2ABLMPOLB
SCHEMBL16378797 0.82 FPR2 (0.44) USP2MEN1KMT2ABLMPOLB
Hydrochloric Acid SCHEMBL18617 0.81 MEN1 (0.60) USP2MEN1KMT2ABLMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411448-A1 CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS Floratek Pharma SA (CH) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411448-A1 CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS BDNF, NTRK2, NGF USP2 4760/4885MEN1 3035/4885KMT2A 4496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback